Translational Cancer Research Centres' Achievements

The Translational Cancer Research Centres (TCRC) program was established in 2011. Its goal was to facilitate collaborations between clinicians and researchers, and support rapid translation of research findings from bench to bedside.

Since 1 July 2021, the Cancer Institute NSW has modified our translational cancer research funding model to build on the success of the original program.

Achievements

Seven TCRCs were established

New collaborations were formed between researchers and clinicians that would not have existed otherwise.

Sydney Catalyst logo
HCRA logo
Kids Cancer Alliance
Sydney Vital logo
CONCERT logo
TCRN logo
Sydney West logo


1,199 members 

1,199 members from 95 institutions who were actively involved in flagship projects.
 

95 participating institutions

The TCRCs bridged administrative and institutional boundaries by bringing together universities, research institutes, hospitals and local health districts.


The impact of the TCRCs

New and strengthened collaborations between researchers and clinicians helped bridge the gap between research and care and have provided capacity for system-wide practice change. 

The HOTTer West Program

This program resulted in: 

  • The Hepatocellular Carcinoma surveillance program commencing in Sydney West.
  • Strong relationships established with local General Practices.
  • Patient and health practitioner resources developed to raise awareness of viral hepatitis detection and management to prevent liver cancer. 

Hereditary cancer program

This program:

  • increased the efficiency and cost‐effectiveness of BRCA gene mutation testing in the area
  • improved dissemination of information about genetic risk among affected families
  • implemented new diagnostic tools to identify Lynch syndrome cases (Hereditary Bowel Cancer).

Communities of Practice

The TCRCs supported the development of communities of practice which met to promote expertise being transferred across organisations and allowed members to work on common priorities. 

The Biobanking Stakeholder Network reduced the fragmentation of biobanks across NSW. Progress was made in:

  • standardising consent processes for unspecified use of specimens and data
  • maximising research using biobanks
  • linking data
  • supporting the work of NSW Pathology and the Ministry of Health.

The Implementation Group Community of Practice supported the translation of research findings into policy and practice. Priority projects addressed:

  • developing an implementation science education program
  • smoking cessation support for cancer patients.

Communities of practice provided a structure for coordination and collaboration between diverse, multidisciplinary research teams.